Table 3.
Clinical and histopathological characteristics of the 70 patients analysed for mRNA level by reverse transcriptase PCR
| Age (years) | |
| Median | 71 |
|
| |
| Range | 36–92 |
|
| |
| Stage, n (%) | |
| I | 34 (49) |
|
| |
| II | 12 (17) |
|
| |
| III | 17 (24) |
|
| |
| IV | 7 (10) |
|
| |
| Subtype, n (%) | |
| Endometrioid | 42 (60) |
|
| |
| CCC + serous | 28 (40) |
|
| |
| Grade (FIGO), n (%) | |
| I | 16 (23) |
|
| |
| II | 16 (23) |
|
| |
| III | 38 (54) |
|
| |
| Grade (nuclear), n (%) | |
| 1 | 10 (14) |
|
| |
| 2 | 22 (32) |
|
| |
| 3 | 38 (54) |
|
| |
| Tumour size (mm), n (%) | |
| ≤20 | 6 (9) |
|
| |
| >20 | 64 (91) |
|
| |
| Depth of myometrial invasion (%), n (%) | |
| ≤50 | 41 (59) |
|
| |
| ×50 | 29 (41) |
|
| |
| LVI, n (%) | |
| No | 41 (59) |
|
| |
| Yes | 29 (41) |
|
| |
| Skil, n (%) | |
| Negative | 25 (36) |
|
| |
| Positive | 45 (64) |
|
| |
| DAB2, n (%) | |
| Negative | 54 (77) |
|
| |
| Positive | 16 (23) |
|
| |
| Recurrence, n (%) | |
| No | 43 (61) |
|
| |
| Yes | 23 (33) |
|
| |
| Others | 4 (6) |
|
| |
| Status, n (%) | |
| Alive with no evidence of disease | 47 (67) |
|
| |
| Alive with evidence of disease | 13 (18) |
|
| |
| Dead of disease | 8 (11) |
|
| |
| Others | 2 (3) |
CCC, clear cell carcinoma; FIGO, International Federation of Gynecology and Obstetrics; LVI, lymphovascular invasion.